Breaking News, Collaborations & Alliances

Scorpius Partners with KaloCyte to Enhance Manufacturing Efficiencies for ErythroMer

Aims to accelerate the lead candidate’s journey toward clinical development.

Author Image

By: Charlie Sternberg

Associate Editor

Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has entered a collaboration with KaloCyte, a pre-clinical company in the field of therapeutic innovation, under which Scorpius will utilize its scientific and technical expertise to enhance manufacturing efficiencies for KaloCyte’s lead candidate, ErythroMer. ErythroMer is a dried, bio-inspired artificial red blood cell designed to address life-threatening blood loss in situations where stored re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters